Gene · 6314
Papers1,627
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,627
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer. | Cells | 2023 | 37508580 | PubTator, text mining | PubMed |
| Homozygous deep intronic variant in SNX14 cause autosomal recessive Spinocerebellar ataxia 20: a case report. | Front Genet | 2023 | 37485342 | PubTator, text mining | PubMed |
| Spinocerebellar ataxia type 8 presents as progressive supranuclear palsy. | Neurosciences (Riyadh) | 2023 | 37482381 | PubTator, text mining | PubMed |
| Loss of PML nuclear bodies in familial amyotrophic lateral sclerosis-frontotemporal dementia. | Cell Death Discov | 2023 | 37454169 | PubTator, text mining | PubMed |
| A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A. | J Neurol | 2023 | 37418012 | PubTator, text mining | PubMed |
| Diagnostic utility of movement disorder society criteria for multiple system atrophy. | Front Aging Neurosci | 2023 | 37396656 | PubTator, text mining | PubMed |
| Neurological Phenotypes of IRF2BPL Gene Variants: A Report of Four Novel Variants. | J Cent Nerv Syst Dis | 2023 | 37346291 | PubTator, text mining | PubMed |
| New Insights into the Roles of p53 in Central Nervous System Diseases. | Int J Neuropsychopharmacol | 2023 | 37338366 | PubTator, text mining | PubMed |
| Spinocerebellar Ataxia Type 35 Caused by a New TGM6 Variant: Video Documentation of a German Family. | Mov Disord Clin Pract | 2023 | 37332650 | PubTator, text mining | PubMed |
| Spinocerebellar Ataxia 36 is a Frequent Cause of Hereditary Ataxia in Eastern Spain. | Mov Disord Clin Pract | 2023 | 37332636 | PubTator, text mining | PubMed |
| Characteristic MR Imaging Features and Serial Changes in Adult-Onset Alexander Disease: A Case Report. | J Korean Soc Radiol | 2023 | 37324989 | PubTator, text mining | PubMed |
| Case report: Frontotemporal dementia and amyotrophic lateral sclerosis caused by a missense variant (p.Arg89Trp) in the valosin-containing protein gene. | Front Genet | 2023 | 37303947 | PubTator, text mining | PubMed |
| Splicing Modulators Are Involved in Human Polyglutamine Diversification via Protein Complexes Shuttling between Nucleus and Cytoplasm. | Int J Mol Sci | 2023 | 37298574 | PubTator, text mining | PubMed |
| Homo cerevisiae-Leveraging Yeast for Investigating Protein-Protein Interactions and Their Role in Human Disease. | Int J Mol Sci | 2023 | 37298131 | PubTator, text mining | PubMed |
| First families with spinocerebellar ataxia type 7 in Poland. | Neurol Neurochir Pol | 2023 | 37283503 | PubTator, text mining | PubMed |
| Genome sequencing with comprehensive variant calling identifies structural variants and repeat expansions in a large fraction of individuals with ataxia and/or neuromuscular disorders. | Front Neurol | 2023 | 37273706 | PubTator, text mining | PubMed |
| Parkinsonism in spinocerebellar ataxia with axonal neuropathy caused by adult-onset COA7 variants: a case report. | BMC Neurol | 2023 | 37264311 | PubTator, text mining | PubMed |
| Reactive Bergmann glia play a central role in spinocerebellar ataxia inflammation via the JNK pathway. | J Neuroinflammation | 2023 | 37237366 | PubTator, text mining | PubMed |
| Coaggregation of polyglutamine (polyQ) proteins is mediated by polyQ-tract interactions and impairs cellular proteostasis. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37171184 | PubTator, text mining | PubMed |
| Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile. | Breast Cancer Res | 2023 | 37161532 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6314/papers?page=7